Inactive Instrument

Highlights Biofrontera AG OTC Markets

Equities

BFRA

US09075G1058

Highlights

Unlock all the news: Be the first to know and act before the market!

Biofrontera Announces the Launch of A New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp	Jun. 24	CI
Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 31	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	May. 15	MT
Reverse Split: 1 of 21; Rights Issue: 1 new share @ 1.1 EUR of 1 existing share	May. 13	FA
Rights Issue: 1 new share @ 1.1 EUR for 1 existing share	May. 13	FA
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q3 Revenue $8.9M, vs. Street Est of $8.4M	Nov. 09	MT
Biofrontera AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q2 Revenue $5.8M	23-08-11	MT
Biofrontera Launches Novel Belixos Active Care	23-07-05	CI
Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-31	CI
Biofrontera AG Completes Patient Recruitment of Ameluz Phase I Trial	23-05-17	CI
Biofrontera Says it Obtained US Patent for New Photodynamic Therapy Protocol	23-05-15	MT
Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $8.7M, vs. Street Est of $9.2M	23-05-12	MT
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Biofrontera AG Establishes UK Subsidiary to Strengthen Its Sales Activities in the Country	22-12-08	CI
Biofrontera Ag Continues to Adhere to Forecast for Fiscal Year 2022	22-11-23	CI
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-23	CI
Earnings Flash (BFRI) BIOFRONTERA Reports Q3 Revenue $4.3M, vs. Street Est of $4.3M	22-11-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Biofrontera AG OTC Markets

Equities

BFRA

US09075G1058

Highlights

Filters